Results 281 to 290 of about 478,465 (344)
Results and clinical implication of repeat endomyocardial biopsy (EMB). Abstract Aims While the diagnostic role of endomyocardial biopsy (EMB) in myocarditis is unquestioned, little is known about its indications and clinical value during long‐term follow‐up.
Anna Baritussio+12 more
wiley +1 more source
A comparative analysis of CT angiography and echocardiography in the evaluation of chest findings in patients with interrupted aortic arch. [PDF]
Moldakhanova Z+7 more
europepmc +1 more source
Temporary RVAD support following HM3 LVAD is associated with high morbidity and mortality. Temporary RVAD support occurs most frequently in INTERMACS 1 or 2 patients and those who require pre‐operative VA‐ECMO. In addition to higher post‐operative mortality, a significantly higher risk of both dialysis and stroke at 1 year post‐implant was observed in ...
Vinh Q. Chau+12 more
wiley +1 more source
The figure illustrates the study design and key findings related to right ventricular myocardial work (RVMW) in heart failure with reduced ejection fraction (HFrEF) patients with and without pulmonary hypertension (PH). Patients were stratified into two groups: those with PH (n = 53) and those without PH (n = 49), as determined by right heart ...
Paolo Manca+12 more
wiley +1 more source
The Role of Right Ventricular Embryology in Echocardiographic Assessment of RV Function. [PDF]
Alnaami G.
europepmc +1 more source
Abstract Aims We aim to assess the efficacy of congestion relief and safety associated with adding SGLT2i (viz., dapagliflozin 10 mg) to intravenous loop diuretics within 24 h of hospital presentation in patients with acute heart failure (AHF). Methods and results A single‐centre open‐label clinical research study enrolled 98 patients admitted with an ...
Daniela Mocan+7 more
wiley +1 more source
A Diagnostic Dilemma Upon Discovery of a Left Ventricle Mass: A Case Report. [PDF]
Alimi H, Tajik A.
europepmc +1 more source
Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Using the National Health Insurance Service database, we
Mi‐Hyang Jung+8 more
wiley +1 more source